Skip to main content
Year archive

Symrise AG — 2026 filings

All 32 regulatory filings released by Symrise AG (SY1) in 2026, sourced directly from the official regulator.

32 Filings
2026 Period
2026 filings (32)
Filing Released Lang
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-20 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-18 English
Q1 statement / Q1 financial report 2026
Earnings Release Q1 2026
2026-05-18 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-12 English
Symrise AG: Michael Friede, buy
Director's Dealing
2026-05-05 English
Regulatory Filings 2026
Regulatory Filings
2026-05-05 English
Release of a capital market information
Regulatory Filings
2026-05-04 English
Symrise reports solid Q1 2026 sales results and reaffirms 2026 outlook
Earnings Release Q1 2026
2026-04-29 English
Release of a capital market information
Transaction in Own Shares
2026-04-27 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-20 English
Release of a capital market information
Transaction in Own Shares
2026-04-13 English
Release of a capital market information
Transaction in Own Shares
2026-04-07 English
Release of a capital market information
Transaction in Own Shares
2026-03-30 English
Symrise AG: Bekanntmachung der Einberufung zur Hauptversammlung am 06.05.2026 in Stadthalle Holzminden, Sollingstrae 101, 37603 Holzminden mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2026-03-26 German
Release of a capital market information
Transaction in Own Shares
2026-03-23 English
Release of a capital market information
Transaction in Own Shares
2026-03-16 English
Annual financial report 2025
Annual Report FY 2025
2026-03-13 English
Release of a capital market information
Transaction in Own Shares
2026-03-09 English
Symrise AG: Michael Konig, buy
Director's Dealing
2026-03-07 English
Symrise AG: Dr. Stephanie Comann, buy
Director's Dealing
2026-03-05 English
Symrise delivered solid organic sales growth and strong profitability improvement for 2025
Earnings Release FY 2025
2026-03-04 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-03-02 English
Release of a capital market information
Transaction in Own Shares
2026-02-23 English
Release of a capital market information
Transaction in Own Shares
2026-02-16 English
Symrise AG: Dr. Stephanie Comann, buy
Director's Dealing
2026-02-12 English
Release of a capital market information
Transaction in Own Shares
2026-02-09 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-02-04 English
Release of a capital market information
Transaction in Own Shares
2026-01-30 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-01-15 English
Symrise AG: Michael Friede, buy
Director's Dealing
2026-01-13 English
Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment.
Regulatory Filings
2026-01-12 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-01-02 English